• Organization: U.S. Department of Health & Human Services
• Updated: 2025-09-06

Purpose The present study aimed at evaluating the efficacy of Raltitrexed, a specific thymidilate synthase inhibitor, in patients with advanced colorectal cancer (ACC) in relapse (>8...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-03-17

Zykadia (ceritinib) is a prescription oral tablet made by Novartis Pharmaceuticals Corporation. It is a kinase inhibitor used to treat certain types of lung cancer, such as ALK-positive metastatic...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-09-06

Background 5-fluorouracil remains the standard therapy for patients with advanced/metastatic colorectal cancer. Pre-clinical studies have demonstrated the biological modulation of...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-09-06

Background The relatively rare carcinoma of the ampulla of Vater is a neoplasia with a good prognosis compared to pancreatic cancer. Preoperative staging is important in planning the...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-03-17

TABRECTA (capmatinib) is an oral prescription medication from Novartis Pharmaceuticals Corporation, approved to treat adults with metastatic non-small cell lung cancer (NSCLC) that has a specific...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-03-17

Vectibix (panitumumab) is a prescription monoclonal antibody made by Amgen that targets epidermal growth factor receptors to help treat certain cancers, like metastatic colorectal cancer. It's...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-03-17

Abiraterone Acetate is a prescription oral tablet with 250 mg of the active ingredient, used to treat metastatic castration-resistant prostate cancer in men. It's a generic version manufactured by...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-09-06

Background Loss of activity of tumor suppressor genes is considered a fundamental step in a genetic model of carcinogenesis. Altered expression of the p53 and the Deleted in Colon Cancer...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-09-06

Background Human papillomavirus (HPV) is a crucial etiological factor for cervical cancer (CC) development. From a diagnostic view-point, the consistent presence of HPV in CC allows the...

• html

• Organization: National Aeronautics and Space Administration
• Updated: 2025-04-23

Accumulating data support the concept that ionizing radiation therapy (RT) has the potential to convert the tumor into an in situ individualized vaccine; however this potential is rarely realized...

• html

• Organization: National Aeronautics and Space Administration
• Updated: 2025-04-23

Accumulating data support the concept that ionizing radiation therapy (RT) has the potential to convert the tumor into an in situ individualized vaccine; however this potential is rarely realized...

• html

• Organization: National Aeronautics and Space Administration
• Updated: 2025-08-21

Densely ionizing radiation is a major component of the space radiation environment and has potentially greater carcinogenic effect compared to sparsely ionizing radiation that is prevalent in the...

• none
• none
• none
• none